Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

SPECIES VARIATION IN THE BILIARY EXCRETION OF OUABAIN

JOHN Q. RUSSELL and CURTIS D. KLAASSEN
Journal of Pharmacology and Experimental Therapeutics December 1972, 183 (3) 513-519;
JOHN Q. RUSSELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CURTIS D. KLAASSEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Due to the biliary excretion of ouabain in rats, a specialized transport process has been proposed for the excretion of organic neutral compounds. In the present study, 3H-ouabain (0.08 mg/kg) was administered i.v. to rats, rabbits and dogs and the plasma disappearance and biliary excretion of 3H was measured over a 12-hour period. Ouabain disappeared from the plasma much more rapidly in the rat than in the other two species. Ouabain was also excreted into the bile at a much higher rate by the rat (900 mµg/min/kg) than by the rabbit or dog (20 and 5 mµg/min/kg). In an attempt to explain the above species difference, the plasma, bile and liver concentration 3H was determined 20 minutes after 3H-ouabain was administered. The rat exhibited an overall bile to plasma concentration gradient of 1500, whereas the same gradient was much less for the rabbit (2.9) and dog (9.3). The liver/plasma and bile/liver gradients were both much greater in the rat (20 and 71) than in the rabbit (2.5 and 1.3) or dog (3.3 and 2.7). It would appear that the relative inability of the rabbit and dog to excrete ouahain into the bile is due to a low capacity for transferring ouabain from the plasma to liver and from the liver to bile. This species variation in the biliary excretion of ouabain appears to be an important factor in the resistance of the rat to the toxic effects of ouabain relative to the rabbit and dog.

Footnotes

    • Received May 17, 1972.
    • Accepted July 27, 1972.
  • © 1972 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 183, Issue 3
1 Dec 1972
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SPECIES VARIATION IN THE BILIARY EXCRETION OF OUABAIN
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

SPECIES VARIATION IN THE BILIARY EXCRETION OF OUABAIN

JOHN Q. RUSSELL and CURTIS D. KLAASSEN
Journal of Pharmacology and Experimental Therapeutics December 1, 1972, 183 (3) 513-519;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

SPECIES VARIATION IN THE BILIARY EXCRETION OF OUABAIN

JOHN Q. RUSSELL and CURTIS D. KLAASSEN
Journal of Pharmacology and Experimental Therapeutics December 1, 1972, 183 (3) 513-519;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics